share_log

JonesTrading Initiates Coverage On Dare Bioscience With Buy Rating, Announces Price Target of $6

Benzinga Real-time News ·  Dec 1, 2022 04:56

JonesTrading analyst Catherine Novack initiates coverage on Dare Bioscience (NASDAQ:DARE) with a Buy rating and announces Price Target of $6.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment